Medical Device Network on MSN

GE HealthCare advances Signa MRI portfolio with trio of FDA clearances

The FDA clearance of GE HealthCare’s next-generation Signa products aligns with the company’s multi-year strategy to differentiate its MRI portfolio.
Hosted on MSN

GE HealthCare wins FDA clearances for next-gen SIGNA MRI portfolio

GE HealthCare Technologies Inc. GEHC recently announced FDA 510(k) clearance for three new magnetic resonance (MR) innovations — SIGNA Sprint with Freelium, a 1.5T sealed magnet MRI system; SIGNA Bolt ...
Business Wire

GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology ...
Nasdaq

GE HealthCare Unveils Next-Gen SIGNA MRI Systems to Elevate Efficiency

GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with Freelium, aimed at boosting efficiency, advancing precision diagnostics and ...
Morningstar

GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency

SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in ...